First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.44 USD -7.11% Market Closed
Updated: Apr 26, 2024

ADC Therapeutics SA
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ADC Therapeutics SA
Gross Profit Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Gross Profit
$67m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Gross Profit
CHf130.8m
CAGR 3-Years
8%
CAGR 5-Years
3%
CAGR 10-Years
12%
Idorsia Ltd
SIX:IDIA
Gross Profit
CHf90.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Gross Profit
CHf28.5m
CAGR 3-Years
157%
CAGR 5-Years
115%
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Gross Profit?
Gross Profit
67m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Gross Profit amounts to 67m USD.

What is ADC Therapeutics SA's Gross Profit growth rate?
Gross Profit CAGR 1Y
-68%

Over the last year, the Gross Profit growth was -68%.